A blood immunoassay that measures IgE antibodies directed against individual allergens or allergenic molecular components.
The immune system produces several classes of antibodies, each with a different role in the body’s defences.

In IgE-mediated allergy, the body produces IgE antibodies against allergens that are harmless to most people, such as pollens, dust mites, moulds, foods, venoms or animal danders.
These IgE antibodies can bind to the surface of mast cells and basophils, the cells involved in allergic reactions. On re-exposure to the allergen, activation of these cells can lead to the release of inflammatory mediators, such as histamine, which cause the symptoms.

ImmunoCAP™ specific IgE testing is an advanced blood immunoassay that measures the presence of IgE antibodies directed against individual allergens or allergenic molecular components.
This type of testing is used to objectively document IgE-mediated sensitization when there is a clinical suspicion of allergy, based on symptoms, medical history and exposure context.
A positive specific IgE result does not confirm an allergy diagnosis on its own. It shows that the immune system has produced antibodies against that allergen. The result becomes clinically relevant only when it matches the symptoms.
ImmunoCAP™ specific IgE testing is a diagnostic tool that helps the physician:
